ACTUAL PROBLEMS OF VACCINE PROPHYLAXIS OF HPV-RELATED DESEASES

Cover Page


Cite item

Full Text

Abstract

Human papillomavirus (HPV) is the most common viral infection of the reproductive tract. It can cause HPV-related diseases that lead to serious health problems. Persistent high-risk (HR) human papillomavirus infection is necessary for development of cervical cancer. Vaccination is an eff ective method to prevent HPV-related diseases. The world experience in using of HPV vaccines has shown their safety and high eff ectiveness.

About the authors

T. N. Nikitina

The Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation

Author for correspondence.
Email: nikitina@expmed.ru

PhD, Main Expert,

Moscow

Russian Federation

I. E. Zhuk

The Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation

Email: fake@neicon.ru

Leading Expert,

Moscow

Russian Federation

V. I. Klimov

The Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation

Email: fake@neicon.ru

PhD, Deputy Director of Centre for Planning and Coordination of Scientific Activities,

Moscow

Russian Federation

T. Yu. Kozlova

The Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation

Email: fake@neicon.ru

Category 1 Expert,

Moscow

Russian Federation

D. V. Gorenkov

The Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation

Email: fake@neicon.ru

Category 1 Expert,

Moscow

Russian Federation

References

  1. Report on global sexually transmitted infection surveillance, 2018. Geneva: World Health Organization; 2018. Retrieved from: https://apps.who.int/iris/bitstream/handle/10665/250268/WHO-RHR-16.09-rus.pdf?sequence=1. Accessed 04 Feb 2019.
  2. World Health Organization. Human papillomavirus (HPV) and cervical cancer. Key facts. 2019 Jan 24, 2019. Retrieved from: https://www.who.int/en/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-andcervical-cancer. Accessed 04 Feb 2019.
  3. Bruni L., Albero G., Serrano B., Mena M., Gómez D., Muñoz J., Bosch F. X., de Sanjosé S. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 22 January 2019. Retrived from: http://www.hpvcentre.net/statistics/reports/RUS.pdf. Accessed 04 Feb 2019.
  4. Luostarinen T., Apter D., Dillner J., Eriksson T., Harjula K., Natunen K., Paavonen J., Pukkala E., Lehtinen M. Vaccination protects against invasive HPV-associated cancers. Int J Cancer. 2018; 142(10), 2186–2187.
  5. Зароченцева Н. В., Белая Ю. М. Cовременный взгляд на остроконечные кондиломы: возможности лечения и профилактики. Российский вестник акушера гинеколога. 2017; (1), 109–12.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2019 Nikitina T.N., Zhuk I.E., Klimov V.I., Kozlova T.Y., Gorenkov D.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.